Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)

WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it will begin offering access to Novo Nordisk’s now available Ozempic ® ...
Hosted on MSN

Weight Watchers reinvents itself to capitalize on GLP-1 boom with new platform

WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ...
Seeking Alpha

Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era

NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (WW) (“Weight Watchers”), the global leader in science-backed weight management, today introduced a new, fully integrated experience ...
MobiHealthNews

Weight Watchers adds diabetes-specific program for employers

Weight Watchers announced a new weight loss program for people with type 2 diabetes, which it will provide through its employee wellness offering. The new program, called Weight Watchers for Diabetes, ...